Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Enasidenib-Induced Differentiation Syndrome in IDH2-Mutant Acute Myeloid Leukemia.
See All Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Enasidenib-Induced Differentiation Syndrome in IDH2-Mutant Acute Myeloid Leukemia.
Patel SA. Enasidenib-Induced Differentiation Syndrome in IDH2-Mutant Acute Myeloid Leukemia. JAMA Oncol. 2018 08 01; 4(8):1110-1111.
View in:
PubMed
subject areas
Aminopyridines
Humans
Isocitrate Dehydrogenase
Leukemia, Myeloid, Acute
Triazines
authors with profiles
Shyam Ajay Patel MD, PhD